AMERICAN BANKNOTE CORP
S-3, 1998-01-12
COMMERCIAL PRINTING
Previous: AMERICAN BANKNOTE CORP, S-3, 1998-01-12
Next: AMERICAN BANKNOTE CORP, S-4, 1998-01-12




 As filed with the Securities and Exchange Commission on January 12, 1997 
                                                            File No. 333-
================================================================================


                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                 ---------------

                                    FORM S-3
                             REGISTRATION STATEMENT
                                      UNDER
                           THE SECURITIES ACT OF 1933

                                 ---------------

                          AMERICAN BANKNOTE CORPORATION
             (Exact name of registrant as specified in its charter)

             DELAWARE                                  13-0460520     
- --------------------------------------------------------------------------------
     (State or other jurisdiction                     (IRS Employer   
   of incorporation or organization)                 Identification No.)
                                                  

                                 200 PARK AVENUE
                            NEW YORK, NEW YORK 10166
                                 (212) 557-9100
               (Address, including zip code, and telephone number,
                 including area code, of registrant's principal
                               executive offices)

                             HARVEY J. KESNER, ESQ.
                                 GENERAL COUNSEL
                          AMERICAN BANKNOTE CORPORATION
                                 200 PARK AVENUE
                            NEW YORK, NEW YORK 10166
                                 (212) 557-9100
            (Name, address, including zip code, and telephone number,
                   including area code, of agent for service)

                                    Copy to:

                            SCOTT S. ROSENBLUM, ESQ.
                        KRAMER, LEVIN, NAFTALIS & FRANKEL
                                919 THIRD AVENUE
                            NEW YORK, NEW YORK 10022
                                 (212) 715-9100

         Approximate  date of commencement of proposed sale of the securities to
the  public:  From  time to  time  after  this  Registration  Statement  becomes
effective, as determined by market conditions.

         If the only securities  being registered on this form are being offered
pursuant to dividend or interest  reinvestment plans, please check the following
box. [ ]


<PAGE>

         If any of the  securities  being  registered  on  this  form  are to be
offered  on a  delayed  or  continuous  basis  pursuant  to Rule 415  under  the
Securities Act of 1933,  other than  securities  offered only in connection with
dividend or interest reinvestment plans, check the following box. [x]

         If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following box
and list  the  Securities  Act  registration  statement  number  of the  earlier
effective registration statement for the same offering. [ ] _____________

         If this  Form is a  post-effective  amendment  filed  pursuant  to Rule
462(c) under the Securities Act, check the following box and list the Securities
Act  registration   statement  number  of  the  earlier  effective  registration
statement for the same offering. [ ] _____________________

         If delivery of the  prospectus  is expected to be made pursuant to Rule
434, please check the following box. [ ]

                         CALCULATION OF REGISTRATION FEE

<TABLE>
<CAPTION>
===========================================================================================================================

                                                                   PROPOSED           PROPOSED
                                            AMOUNT                  MAXIMUM            MAXIMUM              AMOUNT OF
    TITLE OF EACH CLASS OF                   TO BE              OFFERING PRICE        AGGREGATE           REGISTRATION
  SECURITIES TO BE REGISTERED             REGISTERED             PER SHARE (1)    OFFERING PRICE (1)           FEE
  ---------------------------             ----------            ---------------   ------------------          ----

<S>                                      <C>                        <C>               <C>                     <C>
Common Stock, $.01 par
value..........................           1,600,000 shares(2)        $5.125           $8,200,000              $2,419
</TABLE>


(1)  Estimated solely for the purpose of calculating the  registration  fee. The
     registration  fee for the shares of Common Stock being  registered  hereby,
     $2,419,  has been  calculated  pursuant to Section 6(b) of, and Rule 457(c)
     under, the Securities Act of 1933, as amended (the "Securities Act"), based
     on the  average  of the high and low sales  prices of the  Common  Stock as
     reported by the New York Stock Exchange on January 5, 1998.

(2)  Includes up to 1,600,000 shares of Common Stock issuable upon conversion of
     the Zero Coupon  Convertible  Subordinated  Debentures  of the Company (the
     "Debentures")  and the  exercise of the Warrants  and  Redemption  Warrants
     issued in connection with the Debentures  (collectively,  the  "Warrants").
     For  purposes  of  estimating  the  number of shares of Common  Stock to be
     included in this Registration Statement,  the Company calculated the number
     of shares of Common Stock issuable in connection with the conversion of the
     Debentures and the exercise of the Warrants  using an arbitrary  conversion
     price and exercise price. In addition to the shares set forth in the table,
     which  represents a good faith estimate of the number of shares  underlying
     the  Debentures and the Warrants,  the amount to be registered  includes an
     indeterminate  number of shares  issuable upon  conversion or in respect of
     the  Debentures  and upon exercise of the  Warrants,  as such number may be
     adjusted as a result of stock splits,  stock  dividends  and  anti-dilution
     provisions  (including the floating rate conversion  mechanism set forth in
     the Debentures) in accordance with Rule 416 under the Securities Act.


         THE REGISTRANT HEREBY AMENDS THIS  REGISTRATION  STATEMENT ON SUCH DATE
OR DATES AS MAY BE NECESSARY TO DELAY ITS  EFFECTIVE  DATE UNTIL THE  REGISTRANT
SHALL FILE A FURTHER AMENDMENT WHICH SPECIFICALLY  STATES THAT THIS REGISTRATION
STATEMENT SHALL  THEREAFTER  BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(A) OF
THE  SECURITIES  ACT OF 1933 OR UNTIL THE  REGISTRATION  STATEMENT  SHALL BECOME
EFFECTIVE  ON SUCH  DATE  AS THE  SECURITIES  AND  EXCHANGE  COMMISSION,  ACTING
PURSUANT TO SAID SECTION 8(A), MAY DETERMINE.


<PAGE>

PROSPECTUS


                        Subject to Completion, Dated January __, 1998

                                1,600,000 SHARES

                                  -------------

                          AMERICAN BANKNOTE CORPORATION
                                 ---------------

                                  COMMON STOCK
                                ($.01 Par Value)
                                 ---------------

         This Prospectus relates to the offer and sale of up to 1,600,000 shares
(the  "Shares") of the common  stock,  $.01 par value (the "Common  Stock"),  of
American Banknote  Corporation,  a Delaware corporation  ("American Banknote" or
the "Company").  The Shares will be offered for sale by certain  stockholders of
the Company (the "Selling Stockholders"), or by pledgees, donees, transferees or
other  successors  in  interest,  from time to time in one or more  transactions
(which may involve block  transactions)  effected on the New York Stock Exchange
(or any national securities exchange or U.S. inter-dealer  quotation system of a
registered  national  securities  association,  on  which  the  Shares  are then
listed), in sales occurring in the public market off such exchange, in privately
negotiated  transactions,  through  the  purchase  or  writing of options on the
Shares, short sales or in a combination of such methods of sale. Such methods of
sale may be conducted at market prices prevailing at the time of sale, at prices
related to such prevailing  market prices or at negotiated  prices.  The Selling
Stockholders  may effect  such  transactions  directly,  or  indirectly  through
broker-dealers  or agents  acting on their behalf,  and in connection  with such
sales,  such  broker-dealers  or agents may receive  compensation in the form of
commissions or discounts from the Selling  Stockholders and/or the purchasers of
the  Shares  for  whom  they may act as agent or to whom  they  sell  Shares  as
principal or both (which  commissions or discounts are not anticipated to exceed
those customary in the types of transactions  involved). To the extent required,
the  names of any  agents  or  broker-dealers,  and  applicable  commissions  or
discounts  and any other  required  information  with respect to any  particular
offer of Shares by the Selling  Stockholders,  will be set forth in a Prospectus
Supplement.  Any securities  covered by this  Prospectus  which qualify for sale
pursuant  to Rule  144  under  the  Securities  Act of  1933,  as  amended  (the
"Securities  Act"),  may be sold  under Rule 144 rather  than  pursuant  to this
Prospectus. See "Selling Stockholders" and "Plan of Distribution."

         The 1,600,000  shares referred to above is an estimate of the number of
shares  offered  hereby.  The  number of  shares  included  in the  registration
statement  of  which  this  Prospectus  is  a  part,  and  offered  hereby,   is
indeterminate,  is subject to adjustment  and could be  materially  less or more
than such  estimated  number  depending on factors  which cannot be predicted at
this date. See "Selling Stockholders."

         None of the  proceeds  from  the  sale  of the  Shares  by the  Selling
Stockholder  will be  received by the  Company.  All  expenses  of  registration
incurred in connection  with this  offering are being borne by the Company,  but
all  brokerage   commissions   and  other  expenses   incurred  by  the  Selling
Stockholders will be borne by the Selling Stockholders.


<PAGE>

         The Selling  Stockholders  and any dealer acting in connection with the
offering of any of the Shares or any broker  executing  selling orders on behalf
of the  Selling  Stockholders  may be deemed  to be  "underwriters"  within  the
meaning of the  Securities  Act of 1933, as amended (the  Securities  Act"),  in
which  event any  profit on the sale of any or all of the Shares by them and any
discounts or  concessions  received by any such brokers or dealers may be deemed
to be underwriting discounts and commissions under the Securities Act.

         The  Common  Stock is traded on the New York  Stock  Exchange  ("NYSE")
under the symbol  "ABN."  The last  reported  sale price of the Common  Stock on
January 5, 1998 was $5.125 per share.

                                 ---------------

       SEE RISK FACTORS BEGINNING ON PAGE 5 FOR CERTAIN INFORMATION THAT
                  SHOULD BE CONSIDERED BY POTENTIAL INVESTORS.
                                 --------------

         THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE
     SECURITIES AND EXCHANGE COMMISSION NOR HAS THE COMMISSION PASSED UPON
       THE ACCURACY OR ADEQUACY OF THIS PROSPECTUS. ANY REPRESENTATION TO
                      THE CONTRARY IS A CRIMINAL OFFENSE.
                                 ---------------

                   The date of this Prospectus is January __, 1998.


                                        2

<PAGE>

                              AVAILABLE INFORMATION

         The  Company  is  subject  to  the  informational  requirements  of the
Securities  Exchange  Act of 1934,  as amended  (the  "Exchange  Act"),  and, in
accordance  therewith,  files reports and other  information with the Securities
and Exchange Commission (the "Commission").  Copies of reports, proxy statements
and other  information filed by the Company with the Commission can be inspected
and copied at the public  reference  facilities  maintained by the Commission at
Room  1024,  450  Fifth  Street,  N.W.,  Washington,  D.C.  20549,  and also are
available for inspection at the  Commission's  regional  offices  located at 500
West  Madison,  Suite 1400,  Chicago,  Illinois  60661 and 7 World Trade Center,
Suite  1300,  New  York,   New  York  10048  and  the   Commission   website  at
(http://www.sec.gov). Copies of such material also can be obtained at prescribed
rates from the Public  Reference  Section of the Commission at 450 Fifth Street,
N.W.,  Washington,   D.C.  20549.  Such  reports,  proxy  statements  and  other
information may also be inspected at the offices of the NYSE at 20 Broad Street,
New York, New York 10005.

         The Company has filed with the Commission a  Registration  Statement on
Form S-3 (together with all amendments  thereto,  the "Registration  Statement")
under the Securities Act with respect to the Shares.  This  Prospectus  does not
contain all of the information set forth in the Registration Statement,  certain
parts of which are omitted in accordance  with the rules and  regulations of the
Commission.  Statements  made  in  this  Prospectus  as to the  contents  of any
contract,  agreement or other document referred to are not necessarily  complete
and, with respect to each such contract, agreement or other document filed as an
exhibit to the  Registration  Statement,  reference is made to the exhibit for a
more complete  description  of the matter  involved,  and each such statement is
deemed qualified in its entirety by such reference.  The Registration  Statement
and the  exhibits  thereto can be inspected  and copied at the public  reference
facilities maintained by the Commission, regional offices and the offices of the
Commission and of the NYSE referred to above.

                 INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE

         The following  documents  filed by the Company with the  Commission are
incorporated by reference in this Prospectus:

         The Company's  Current Reports on Form 8-K/A filed January 24, 1997 and
on Form 8-K filed September 25, 1997, October 9, 1997, October 24, 1997, October
29, 1997,  November 4, 1997,  November 7, 1997,  November 10, 1997, November 17,
1997,  November 24, 1997, November 25, 1997, December 2, 1997, December 8, 1997,
December 10, 1997, December 12, 1997 and January 9, 1998;

         The Company's  Quarterly  Report on Form 10-Q for the quarterly  period
ended  September 30, 1997; The Company's  Quarterly  Report on Form 10-Q for the
quarterly period ended June 30, 1997;

         The Company's  Quarterly  Report on Form 10-Q for the quarterly  period
ended March 31, 1997;

         The  Company's  Annual  Report on Form 10-K for the  fiscal  year ended
December 31, 1996, as amended by Form 10-K/A filed April 30, 1997; and

         The  description  of  the  Common  Stock  contained  in  the  Company's
Registration  Statement on Form 8-B filed with the  Commission  on September 30,
1993 under the Exchange Act,  including any  amendments or reports filed for the
purpose of updating such description.


                                        3

<PAGE>

         All  reports  and  other  documents  filed  by  the  Company  with  the
Commission  pursuant to Section  13(a),  13(c),  14 or 15(d) of the Exchange Act
prior to the  filing of a  post-effective  amendment  which  indicates  that all
securities  offered  hereby have been sold or which  deregisters  all securities
then remaining  unsold,  shall be deemed to be incorporated by reference  herein
and to be a part  hereof  from  the  date  of the  filing  of such  reports  and
documents.

         Any  statement  contained  in a document,  all or a portion of which is
incorporated or deemed to be incorporated by reference  herein,  or contained in
this  Prospectus,  shall be deemed to be modified or superseded  for purposes of
this  Prospectus  to the  extent  that a  statement  contained  herein or in any
subsequently  filed  document which also is or is deemed to be  incorporated  by
reference  herein modifies or supersedes  such statement.  Any such statement so
modified or superseded shall not be deemed, except as so modified or superseded,
to constitute a part of this Prospectus.

         The Company will provide  without charge to each person,  including any
beneficial  owner, to whom a copy of this Prospectus has been delivered,  on the
written or oral request of such person, a copy of any and all of the information
that  has been or may be  incorporated  by  reference  in this  Prospectus  (not
including exhibits to the information that is incorporated by reference into the
information  that this  Prospectus  incorporates).  Such written or oral request
should be directed to the Secretary,  American  Banknote  Corporation,  200 Park
Avenue, New York, New York 10166.

                SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

         CERTAIN  STATEMENTS  IN CERTAIN  DOCUMENTS  INCORPORATED  BY  REFERENCE
HEREIN CONSTITUTE "FORWARD-LOOKING STATEMENTS" WITHIN THE MEANING OF THE PRIVATE
SECURITIES  LITIGATION  REFORM  ACT OF  1995.  SUCH  FORWARD-LOOKING  STATEMENTS
INVOLVE UNKNOWN AND UNCERTAIN RISKS,  UNCERTAINTIES  AND OTHER FACTORS WHICH MAY
CAUSE THE  ACTUAL  RESULTS,  PERFORMANCE  OR  ACHIEVEMENTS  OF THE  COMPANY,  OR
INDUSTRY  RESULTS,   TO  BE  MATERIALLY   DIFFERENT  FROM  ANY  FUTURE  RESULTS,
PERFORMANCE,  OR  ACHIEVEMENTS  EXPRESSED  OR  IMPLIED  BY SUCH  FORWARD-LOOKING
STATEMENTS.  SUCH FACTORS  INCLUDE,  AMONG OTHERS,  THE  FOLLOWING:  (1) GENERAL
ECONOMIC,  POLITICAL,  MARKET AND BUSINESS  CONDITIONS,  WHICH MAY,  AMONG OTHER
THINGS,  AFFECT  DEMAND FOR THE COMPANY'S  PRODUCTS;  (2) INFLATION AND CURRENCY
EXCHANGE  RATES  IN  THOSE  FOREIGN  COUNTRIES  IN WHICH  THE  COMPANY  OPERATES
(INCLUDING  BRAZIL AND  AUSTRALIA/NEW  ZEALAND WHICH ACCOUNTED FOR APPROXIMATELY
53%  AND  16% OF  SALES  AND  63%  AND  16% OF  HISTORICAL  OPERATING  EARNINGS,
RESPECTIVELY,  IN 1996 BEFORE ALLOCATION OF CORPORATE OVERHEAD); (3) NEW PRODUCT
DEVELOPMENT AND  TECHNOLOGICAL  ADVANCES WHICH MAY, AMONG OTHER THINGS,  COMPETE
WITH OR REDUCE THE NEED FOR THE COMPANY'S  PRODUCTS;  (4)  COMPETITION;  (5) THE
LOSS OF ANY OF THE  COMPANY'S  SIGNIFICANT  CUSTOMERS;  AND (6) THE  ABILITY  TO
INTEGRATE  ACQUISITIONS  SUCCESSFULLY.  THESE AND OTHER  FACTORS  AFFECTING  THE
COMPANY'S  BUSINESS  ARE AS DESCRIBED IN THIS  OFFERING  MEMORANDUM,  ESPECIALLY
UNDER "RISK FACTORS" BELOW, AND IN THE COMPANY'S FILINGS WITH THE SECURITIES AND
EXCHANGE  COMMISSION  UNDER THE  SECURITIES  EXCHANGE  ACT OF 1934.  GIVEN THESE
UNCERTAINTIES,  PROSPECTIVE  INVESTORS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE
ON SUCH FORWARD-LOOKING STATEMENTS.


                                        4

<PAGE>

                                   THE COMPANY

         The  Company  is  a  leading  global  provider  of  secure  transaction
solutions, documents and systems. The Company designs solutions and manufactures
products that  incorporate  anti-fraud and counterfeit  resistant  technologies,
including     stored-value     telephone,     magnetic-stripe,     memory    and
microprocessor-based  transaction  cards (smart cards),  holograms,  currencies,
travelers' and other checks,  stock and bond  certificates and a wide variety of
electronically or digitally produced personalized  documents.  The Company sells
these products and services worldwide to financial institutions, governments and
corporations through its operations in the United States, Brazil, Australia, New
Zealand and France.  Through selective  acquisitions and strategic  realignment,
the Company has positioned itself as a full service provider of technology-based
solutions for its customers' secure  transaction  needs. The Company's  products
and  services  are divided  into three  principal  groups:  Transaction  Cards &
Systems,   Printing  Services  &  Document   Management  and  Security  Printing
Solutions.

         Unless the context otherwise  indicates,  references herein to American
Bank  Note  or  the  Company  are  to  American  Banknote  Corporation  and  its
subsidiaries.  The principal executive offices of the Company are located at 200
Park  Avenue,  New  York,  New York  10166,  and its  telephone  number is (212)
557-9100.

                               RECENT DEVELOPMENTS

         The Company has executed  contracts for the  continued  supply of phone
cards for Telebras, Brazil's national telephone company. The Company anticipates
that revenues from these contracts will total  approximately $18 million for the
one-year  period  beginning   December  1997.  In  accordance  with  the  Brazil
privatization  program for  Telebras,  the Company has entered into six separate
agreements with local phone operators Telem, Teleron,  Telems,  Telaima,  Telest
and Telasa for Rio de Janeiro and five other states. Each of the six local phone
operators has the option to extend its contract for a second year.

         The Company has acquired the printing  assets of  Commonwealth  Bank of
Australia  Limited  ("Commonwealth")  for a  purchase  price of  AU$6.5  million
(approximately US$4.6 million). In connection with the purchase, the Company has
entered into a three-year supply agreement for the supply of printed products to
Commonwealth with two three-year extension periods exercisable by Commonwealth.

         The Company has acquired the printing  assets of Bank Itau  ("Itau") in
Brazil for Reals 6 million  (approximately  US$5.5 million).  In connection with
the purchase,  Itau has agreed to a two-year supply  agreement for the supply of
printed products to Itau with two one-year extensions exercisable by Itau.

         The Company has  completed a  refinancing  of certain of the  Company's
outstanding indebtedness (the "Refinancing").  Pursuant to the Refinancing,  the
Company:  (i) sold, in a transaction not registered  under the Securities Act in
reliance on the exemption  therefrom units  consisting of $95,000,000  aggregate
principal  amount of Senior  Subordinated  Notes due 2007 and 95,000 Warrants to
purchase an aggregate  of 1,185,790  shares of Common Stock of the Company at an
exercise  price of $5.50 per share;  (ii)  consummated  the Tender Offer and the
related Consent  Solicitation (each as defined) with respect to the Company's 11
5/8% Senior Notes due 2002 (the "11 5/8% Notes");  and (iii) repaid  outstanding
amounts under the $20.0 million  revolving  credit  facility among ABN, ABNH and
The Chase  Manhattan Bank (as successor to Chemical Bank) (the "Existing  Credit
Facility").

         Pursuant  to a separate  Offer to  Purchase  and  Consent  Solicitation
Statement  dated  September 25, 1997, the Company offered to repurchase all, but
not less than a majority,  of its outstanding 11 5/8% Notes (the "Tender Offer")
for an amount in cash equal to $1,094.47 per $1,000 principal amount of 11


                                        5

<PAGE>

5/8% Notes.  Each tendering  holder also received accrued and unpaid interest up
to, but not  including,  the payment date. In connection  with the Tender Offer,
the Company also solicited consents (the "Consent  Solicitation") from tendering
holders  of 11  5/8%  Notes  to  certain  proposed  amendments  (the  "Indenture
Amendments")  to the  indenture  governing  the 11 5/8%  Notes  ("11 5/8%  Notes
Indenture"), which amendments would, among other things, eliminate substantially
all of the  restrictive  covenants  contained  in the 11 5/8%  Notes  Indenture.
Holders of 11 5/8% Notes who timely tendered received a consent payment equal to
2% of the  principal  amount of the  related  11 5/8% Notes  ($20.00  per $1,000
principal  amount)  (which  consent  payment is  included  in the  tender  price
referred  to  above).  Following  the  tender of 11 5/8%  Notes and  receipt  of
consents  of  holders  of a  majority  of the 11 5/8%  Notes (in excess of $32.5
million  aggregate  principal  amount) on October 8, 1997,  the  Company and the
trustee for the 11 5/8% Notes executed a supplemental  indenture  containing the
Indenture Amendments, which became effective upon acceptance for purchase of the
tendered 11 5/8% Notes on December 12, 1997. In connection with the Tender Offer
and Consent Solicitation,  the Company purchased, and received consents relating
to, approximately 87.7% of the outstanding 11 5/8% Notes.

                                 USE OF PROCEEDS

         The Company will not receive any of the  proceeds  from the sale of the
Shares.  All of the proceeds from the sale of the Shares will be received by the
Selling Stockholders.  Any proceeds received by the Company upon exercise of the
Warrants will be used for general corporate purposes.

                                  RISK FACTORS

         Prospective  purchasers of Shares should carefully  consider all of the
information  set forth in this  Prospectus  and, in  particular,  the  following
factors:

SUBSTANTIAL LEVERAGE AND ABILITY TO SERVICE DEBT

         The Company is highly  leveraged.  At September 30, 1997,  after giving
effect  to the sale of a $5  million  accreted  value  Zero  Coupon  Convertible
Subordinated  Debenture  due 2002 in November 1997 and the  Refinancing  and the
application of the estimated net proceeds  thereof,  the Company would have had:
(i) total consolidated  long-term debt, including the current portion, of $316.2
million;  (ii) total stockholders' equity of $57.6 million; and (iii) a ratio of
earnings to fixed charges for the twelve months ended  September 30, 1997 of 1.2
to 1.

         The degree to which the  Company  is  leveraged  could  have  important
consequences including: (i) the Company's ability to obtain additional financing
for working capital,  capital  expenditures or acquisitions in the future may be
limited;  (ii) a substantial  portion of the Company's cash flow from operations
may be  dedicated  to  the  payment  of the  principal  of and  interest  on its
indebtedness,  thereby  reducing  funds  available for future  operation;  (iii)
certain  of  the  Company's  borrowings,  including  all  borrowings  under  the
Company's credit facilities are at variable rates of interest, which exposes the
Company to the risk of  increased  interest  rates;  and (iv) the Company may be
more vulnerable to economic downturns and be limited in its ability to withstand
competitive  pressures.  Certain  of the  Company's  competitors  may  currently
operate on a less leveraged basis and therefore the Company could be placed at a
disadvantage  relative  to its  competitors  which  have  significantly  greater
operating and financing  flexibility than the Company.  The Company's ability to
make  scheduled  payments of the principal or interest on, or to refinance,  its
indebtedness  will  depend on its future  operating  performance  and cash flow,
which are subject to prevailing  economic  conditions,  prevailing interest rate
levels, and financial,  competitive,  business and other factors,  many of which
are beyond its control.  The Company  believes that,  based on current levels of
operations, it should be able to meet its debt obligations when due. However, if
the Company cannot  generate  sufficient  cash flow from  operations to meet its
debt


                                        6

<PAGE>

service  obligations,  then the  Company  might be  required  to  refinance  its
indebtedness and may be forced to adopt an alternative strategy that may include
actions  such as reducing  or delaying  capital  expenditures,  selling  assets,
restructuring  or refinancing its  indebtedness,  or seeking  additional  equity
capital. There is no assurance that refinancings would be permitted by the terms
of  its  credit   facilities  or  indentures  or,  along  with  the  alternative
strategies, could be effected on satisfactory terms.

RESTRICTIONS IMPOSED BY TERMS OF INDEBTEDNESS

         The Company's  indentures contain numerous  restrictive  covenants that
limit the  discretion  of the  Company's  management  with  respect  to  certain
business matters. These covenants will place significant  restrictions on, among
other things,  the ability of the Company to incur additional  indebtedness,  to
create liens or other  encumbrances,  to pay  dividends  or make  certain  other
payments,  investments, loans and guarantees and to sell or otherwise dispose of
assets and merge or  consolidate  with  another  entity.  The  Company's  credit
facilities  also contain a number of financial  covenants  that will require the
Company to meet certain  financial  ratios and financial  condition  tests.  The
Company's  ability to meet these financial ratios and financial  condition tests
can be affected by events beyond its control, and there can be no assurance that
the Company  will meet such  ratios or such tests.  A failure to comply with the
obligations in its credit  facilities or indentures  could result in an event of
default under other  agreements or  instruments  to which the Company is a party
that,  if not  cured  or  waived,  could  permit  acceleration  of the  relevant
indebtedness and acceleration of indebtedness  under other  instruments that may
contain cross-acceleration or cross-default provisions. In the event of an event
of default the lenders thereunder could elect to declare all amounts outstanding
thereunder, together with accrued and unpaid interest, to be immediately due and
payable. If indebtedness were to be accelerated,  there can be no assurance that
the assets of the Company would be sufficient to repay in full that indebtedness
and the other indebtedness of the Company. Other indebtedness of the Company and
its  subsidiaries  that may be incurred in the future may contain  financial  or
other covenants more restrictive than those described herein.

SUBORDINATION; HOLDING COMPANY STRUCTURE

         The Company is a holding  company that has no significant  assets other
than  its  direct  and  indirect  investments  in  its  operating  subsidiaries.
Accordingly,  the Company  must rely on its  subsidiaries  to generate the funds
necessary  to meet its  obligations,  including  the payment of principal of and
interest  on its  debt  instruments.  The  ability  of the  subsidiaries  to pay
dividends or make other  payments or advances  will depend upon their  operating
results  and will be subject to  applicable  laws and  contractual  restrictions
contained in the instruments  governing any  indebtedness of such  subsidiaries.
Certain  of the  Company's  subsidiaries  have  incurred,  and in the future may
incur,  indebtedness.  As a  result,  cash  flow  from  the  operations  of such
subsidiaries may be dedicated to the payment of principal of and interest on the
indebtedness  of  such  subsidiaries,  thereby  limiting  the  ability  of  such
subsidiaries  to pay dividends.  In addition,  any dividends  declared by a less
than wholly owned  subsidiary  will be paid on a pro rata basis to the owners of
such subsidiary.

FOREIGN OPERATIONS

         The Company's financial  performance on a dollar-denominated  basis can
be significantly  affected by changes in currency  exchange rates. The Company's
foreign  exchange  exposure  policy  generally  calls for selling  its  domestic
manufactured  product in US dollars and, in the case of its foreign manufactured
product,  selling in the  national  currencies  of the  countries  in which such
subsidiaries operate, in order to minimize transactions  occurring in currencies
other than those of the originating country. The Company may, from time to time,
enter into  foreign  currency  option  contracts to limit the effect of currency
fluctuations  on future  expected  cash  receipts to be used for parent  company
purposes,  including debt service.  Such  activities may be  discontinued at any
time depending on, among other things,


                                        7

<PAGE>

management's  views  concerning  future  exchange  rates  and  the  cost of such
contracts.  The  Company  has not  engaged in  material  hedging  activities  in
connection  with foreign  operations.  Adverse  changes in foreign  interest and
exchange rates could adversely affect the Company's ability to meet its interest
and principal obligations as well as applicable financial covenants with respect
to its debt.

         Earnings on foreign  investments,  including operations and earnings of
foreign  companies in which the Company may invest or upon which it may rely for
sales,  are  subject  to a number of  general  risks,  including  high  rates of
inflation,  currency  exchange  rate  fluctuations,   trade  barriers,  exchange
controls,  government  expropriation and political  instability and other risks.
These factors may affect the results of operations in selected  markets included
in the Company's growth strategy.  Dividends or distributions from the Company's
foreign  operations  could be subject to government  restrictions in the future.
Currently,  repatriation  of earnings from the Company's  foreign  operations is
permitted.

         The  Company   operates  in  Brazil,   which  in  past  years  suffered
hyperinflationary  conditions;   however,  the  inflation  rate  in  Brazil  has
decreased  substantially to  approximately  4.1% for the first half of 1997, 10%
for 1996 and 23% for 1995 as compared to 941% for 1994.  Inflation  and currency
exchange rate  fluctuation  in countries in which the Company  generates a large
portion of its sales and earnings  (including Brazil and Australia/New  Zealand,
which  accounted  for  approximately  53%  and 16% of  sales  and 63% and 16% of
operating  earnings,  respectively,  in 1996,  before  allocation  of  corporate
overhead) could in the future adversely affect the Company.

         Actions taken by foreign  governments could have an important effect on
the Company's foreign operations.  Political,  economic or social instability or
other developments could adversely affect these companies'  financial conditions
or results of operations and thereby  adversely affect the Company's  ability to
repay its indebtedness and that of its  subsidiaries.  There can be no assurance
that substantially greater governmental  restrictions will not be imposed in the
future,  including  restrictions or  prohibitions on the  repatriation of funds.
Furthermore,  remittances of dividends from any foreign subsidiaries acquired or
formed by the Company in the future may be subject to certain  withholding taxes
and other governmental restrictions.

FOREIGN TAXES

         Earnings of foreign  subsidiaries  are subject to foreign  income taxes
that  reduce  cash  flow  available  to meet  required  debt  service  and other
obligations of the Company.  The Company  presently  cannot utilize  foreign tax
credits  in the  United  States  until its  domestic  net  operating  loss carry
forwards are exhausted.

         The Company has from time to time reorganized and restructured, and may
in the future  reorganize  and  restructure,  its  foreign  operations  based on
certain  assumptions  about the various tax laws  (including  capital  gains and
withholding tax),  foreign currency  exchange and capital  repatriation laws and
other  relevant  laws of a variety of foreign  jurisdictions.  While  management
believes  that such  assumptions  are correct,  there can be no  assurance  that
foreign  taxing or other  authorities  will reach the same  conclusion.  If such
assumptions are incorrect,  or if such foreign  jurisdictions  were to change or
modify  such laws,  the  Company  may  suffer  adverse  tax and other  financial
consequences  which  could  impair the  Company's  ability  to meet its  payment
obligations on the Notes and its other indebtedness.

MAJOR CUSTOMERS; GOVERNMENT SALES

         The  Company  has  several key  customers.  Sales  under  contracts  of
stored-value phone cards to Telebras,  the Brazilian national telephone company,
accounted for approximately 13% and 24% of the Company's  consolidated sales for
the years ended December 31, 1995 and 1996, respectively. The


                                        8

<PAGE>

Company  expects that revenues from sales of phone cards to Telebras during 1997
will  account  for  less  than  15% of the  Company's  consolidated  sales.  The
Company's  contract with Telebras  extends  through  November 1997.  Telebras is
currently  negotiating the terms of future supply arrangements with the Company,
as well as with its other suppliers. Sales of products and services to Bradesco,
Latin America's largest private bank, accounted for 12% and 14% of the Company's
consolidated sales for the years ended December 31, 1995 and l996, respectively.
Sales of food coupons to the United States  Department of  Agriculture  ("USDA")
accounted for approximately 22%, 11% and 5% of the Company's  consolidated sales
for the years ended December 31, 1994, 1995 and 1996, respectively. In September
1996, the USDA awarded ABN a contract for the production of food coupons through
September 30, 1997 with a one-year  option,  which option has been  exercised by
USDA. The contract is expected to represent sales of  approximately  $14 million
per year.

         There can be no assurance as to whether, or when, or on what terms, the
Company will be awarded any contracts from these customers,  including Telebras,
in the future, especially those that are subject to competitive bids. There also
can be no assurance that any options for continued  production  under any of the
Company's contracts will be exercised.  In addition, the Brazilian government is
expected to proceed with a plan for the  privatization of Telebras,  which could
result in a split up of Telebras into five or six smaller  companies,  which may
result  in  multiple  competitive  bids in  future  years.  The loss of all or a
significant  portion of the Company's  business with these entities would have a
material adverse effect on the sales and earnings of the Company.

         Each of the  agencies  of the United  States  government  for which the
Company  provides  products  or  services  acts  independently  of the others in
soliciting bids.  Government  contracts are generally  awarded on the basis of a
competitive  bidding  process and a variety of other factors,  which may include
price,  plant  security,  manufacturing  controls,  a  preference  for  domestic
contractors  and past  performance.  In addition,  contracts  with  governmental
agencies generally contain provisions permitting  termination at any time at the
convenience  of the  agency  and give the  agency  the  right to audit  contract
compliance and adjust the contract amount for noncompliance.

ABILITY TO INTEGRATE ACQUISITIONS

         A core  part of the  Company's  business  strategy  is to grow  through
strategic  acquisitions,  joint ventures and alliances.  The Company's financial
condition  could  be  adversely  affected  if the  Company  cannot  successfully
integrate acquired  businesses into its existing operations or if the Company is
required to materially  increase the amount of its financial  commitment to such
acquisitions,  joint  ventures or alliances.  In addition,  the Company may seek
strategic  acquisitions,  joint ventures or alliances in countries or markets in
which it does not currently operate.  There can be no assurance that the Company
will be able to successfully integrate or manage such operations.

COMPETITION

         The Company's principal subsidiaries conduct their businesses in highly
competitive markets.  Competition in the Company's product markets is based upon
service, quality, reliability and price. In certain markets in which the Company
competes,  some of the Company's  competitors  have greater  financial and other
resources than the Company.

         The  future  of the  Company's  food  coupon  printing  is  subject  to
competition from electronic  card-based  Electronic  Benefits  Transaction (EBT)
systems. In addition, benefit reforms and levels of food coupon inventory caused
a reduction in the Company's 1996 food coupon production volume and continues to
impact the USDA's food coupon orders.  The elimination or a reduction in the use
of paper food  coupons  would have a  material  adverse  effect on the sales and
earnings of the Company.


                                        9

<PAGE>

SALES OF STOCK AND BOND CERTIFICATES

         Stock and bond printing  accounted for approximately 14%, 11% and 8% of
the Company's consolidated sales for the years ended December 31, 1994, 1995 and
1996,  respectively.  The  Company's  overall  volume of sales of stock and bond
certificates  increased in 1996,  but declined as a percent of sales as a result
of  increases  in  consolidated  sales.  Sales of stock  and bond  certificates,
primarily a domestic product, are a function of trading activity,  the number of
public offerings,  the mix of debt and equity security  issuances and regulatory
considerations.  The elimination of  certificates  has been advocated by various
organizations in favor of the use of book-entry  systems for recording  security
ownership. Security sales to institutions, which have been growing, have reduced
demand for printed  certificates,  particularly for debt issues.  Domestic stock
and bond  printing  has  historically  accounted  for a sizeable  portion of the
security  printing sales of the Company.  The Company's  sales of stock and bond
certificates  increased  from  1995 to 1996 as a result of the  increase  in new
issues,  stock splits and stock  distributions  (due to greater  activity in the
domestic securities markets).  No assurance can be given, however, that the high
level  of  activity  in the  domestic  securities  markets  will  continue.  The
elimination of or a substantial  reduction in the use of certificates would have
a material adverse effect on the sales and earnings of the Company.

DEPENDENCE ON KEY PERSONNEL

         The Company is  dependent  on the  services  of its senior  management,
including  Morris Weissman,  Chairman of the Board and Chief Executive  Officer,
and the loss of their services could have an adverse effect on the Company.  The
Company has entered  into  employment  agreements  with  several  members of its
senior management, including Mr. Weissman.


                                       10

<PAGE>

                              SELLING STOCKHOLDERS

         The  Shares  were  issued in a  private  placement  transaction  to the
Selling  Stockholders.  The following table sets forth certain  information with
respect to the Selling Stockholders as of December 31, 1997, as follows: (i) the
name and address of the Selling  Stockholders;  (ii) the number of the Company's
outstanding   shares  of  Common  Stock   beneficially  owned  by  each  Selling
Stockholder  (including shares obtainable under options exercisable within sixty
(60) days of such date) prior to the offering hereby; (iii) the number of shares
of Common Stock being offered hereby;  and (iv) the number and percentage of the
Company's  outstanding  shares of Common Stock to be  beneficially  owned by the
Selling  Stockholders after completion of the sale of Common Stock being offered
hereby. There can be no assurance that the Selling Stockholders will sell all of
the shares being offered hereby.

<TABLE>
<CAPTION>
                             Beneficial Ownership                         Beneficial Ownership
Selling Stockholder        at December 31, 1997(1)                           After Offering
- -------------------        -----------------------        Number of          ---------------
                                                        Shares Covered  
                                    Number                 by this           Number      Percent
                                  of Shares               Prospectus       of Shares    of Class
                                  ---------               ----------       ---------    --------

<S>                               <C>                     <C>              <C>             <C> 
RGC International                  2,377,759(2)           1,280,000        1,097,759       4.9%(2)
  Investors LDC


Halifax Fund L.P.                    320,000(3)             320,000           0               *

- --------------------------------------------------------------------------------------------------
Total                              2,697,759              1,600,000        1,097,759        4.9%
</TABLE>

                                                                  * Less than 1%

(1)    The  information  contained  in the  table  above  reflects  "beneficial"
       ownership  of the Common Stock within the meaning of Rule 13d-3 under the
       Exchange  Act. On December  31,  1997,  there were  20,853,769  shares of
       Common Stock outstanding.
(2)    The number of shares set forth in the table represents an estimate of the
       number  of  shares  of  Common  Stock  to  be  offered  by  this  Selling
       Stockholder  hereby,  as well as an  estimate  of the  number  of  shares
       issuable  upon  conversion  of the  outstanding  principal  amount of the
       Company's Zero Coupon Convertible  Subordinated  Debenture dated July 24,
       1997 (the "July Debenture"),  plus warrants to purchase 215,000 shares of
       Common Stock issued in connection  therewith (the "July  Warrants").  The
       actual number of shares of Common Stock  issuable upon  conversion of the
       Debentures  and the July  Debenture  and exercise of the Warrants and the
       July Warrants is  indeterminate,  is subject to  adjustment  and could be
       materially less or more than such estimated  number  depending on factors
       which cannot be predicted by the Company at this time,  including,  among
       other  factors,  the future market price of the Common Stock.  The actual
       number of shares of Common  Stock  offered  hereby,  and  included in the
       Registration  Statement of which this Prospectus is a part, includes such
       additional  number of shares of Common Stock as may be issued or issuable
       upon  conversion of the Debentures and exercise of the Warrants by reason
       of the floating  rate  conversion  price  mechanism  or other  adjustment
       mechanisms  described  therein,  or by reason of any stock  split,  stock
       dividend or similar  transaction  involving the Common Stock, in order to
       prevent  dilution,  in accordance with Rule 416 under the Securities Act.
       Pursuant to the terms of the Debentures, the Warrants, the July Debenture
       and the July Warrants,  the Debentures,  the Warrants, the July Debenture
       and the July Warrants are  convertible  or exercisable by any holder only
       to the extent that the number of shares of Common Stock thereby issuable,
       together  with the number of shares of Common  Stock owned by such holder
       and its affiliates (but not including  shares of Common Stock  underlying
       the  unconverted  portion of the  Debentures or the July Debenture or the
       unexercised portions of the Warrants or July Warrants) would not exceed


                                       11

<PAGE>


       4.9% of the then  outstanding  Common Stock as  determined  in accordance
       with Section 13(a) of the Exchange Act. Accordingly, the number of shares
       of Common  Stock set  forth in the  table  for this  Selling  Stockholder
       exceeds  the  number  of  shares  of  Common   Stock  that  this  Selling
       Stockholder  could own  beneficially  at any  given  time  through  their
       ownership of the  Debentures,  the Warrants,  the July  Debenture and the
       July  Warrants.  In that  regard,  beneficial  ownership  of this Selling
       Stockholder  set forth in the table is not determined in accordance  with
       Rule 13d-3 under the Exchange Act.

(3)    The number of shares set forth in the table represents an estimate of the
       number  of  shares  of  Common  Stock  to  be  offered  by  this  Selling
       Stockholder.  The actual  number of shares of Common Stock  issuable upon
       conversion   of  the   Debentures   and   exercise  of  the  Warrants  is
       indeterminate,  is subject to adjustment and could be materially  less or
       more than such  estimated  number  depending  on factors  which cannot be
       predicted by the Company at this time,  including,  among other  factors,
       the future market price of the Common Stock.  The actual number of shares
       of  Common  Stock  offered  hereby,  and  included  in  the  Registration
       Statement of which this  Prospectus is a part,  includes such  additional
       number  of shares of  Common  Stock as may be  issued  or  issuable  upon
       conversion  of the  Debentures  and exercise of the Warrants by reason of
       the  floating  rate  conversion   price  mechanism  or  other  adjustment
       mechanisms  described  therein,  or by reason of any stock  split,  stock
       dividend or similar  transaction  involving the Common Stock, in order to
       prevent  dilution,  in accordance with Rule 416 under the Securities Act.
       Pursuant to the terms of the Debentures and the Warrants,  the Debentures
       and the Warrants are convertible or exercisable by any holder only to the
       extent  that the  number  of shares of  Common  Stock  thereby  issuable,
       together  with the number of shares of Common  Stock owned by such holder
       and its affiliates (but not including  shares of Common Stock  underlying
       the unconverted portion of the Debentures or the unexercised  portions of
       the Warrants) would not exceed 4.9% of the then outstanding  Common Stock
       as  determined  in  accordance  with Section  13(a) of the Exchange  Act.
       Accordingly,  the number of shares of Common Stock set forth in the table
       for this Selling Stockholder exceeds the number of shares of Common Stock
       that this Selling  Stockholder  could own  beneficially at any given time
       through  their  ownership of the  Debentures  and the  Warrants.  In that
       regard, beneficial ownership of this Selling Stockholder set forth in the
       table is not determined in accordance  with Rule 13d-3 under the Exchange
       Act.


                                       12

<PAGE>

                              PLAN OF DISTRIBUTION

       The Selling  Stockholders have advised the Company that the Shares may be
sold  from  time to time by the  Selling  Stockholders,  or by their  respective
pledgees,  donees,  transferees or other successors in interest,  in one or more
transactions on the New York Stock Exchange (or any national securities exchange
or  U.S.  automated  interdealer  quotation  system  of  a  registered  national
securities  association  on which  shares of Common Stock are then  listed),  in
sales  occurring  in  the  public  market  off  such  exchange,   in  negotiated
transactions,  through the  purchase or writing of options on the Shares,  short
sales or in a  combination  of such methods of sale.  The Shares will be sold at
prices  and on terms then  prevailing,  at prices  related  to the  then-current
market  price of the  Shares,  or at  negotiated  prices.  The  Company has been
advised that the Selling  Stockholders  may effect sales of the Shares directly,
or indirectly by or through agents or broker-dealers  and that the Shares may be
sold  by  one  or  more  of  the  following  methods:   (a)  ordinary  brokerage
transactions,  (b) purchases by a broker-dealer  as principal and resale by such
broker-dealer for its own account, and (c) in "block" sale transactions.  At the
time a particular offer is made, a Prospectus Supplement,  if required,  will be
distributed that sets forth the name or names of agents or  broker-dealers,  any
commissions  and other terms  constituting  selling  compensation  and any other
required information.  Moreover, in effecting sales,  broker-dealers  engaged by
the Selling  Stockholders  and/or the  purchasers  of the Shares may arrange for
other  broker-dealers  to participate in the sale process.  Broker-dealers  will
receive  discounts  or  commissions  from the  Selling  Stockholders  and/or the
purchasers of the Shares in amounts  which will be negotiated  prior to the time
of sale. Sales will be made only through broker-dealers  registered as such in a
subject  jurisdiction  or in  transactions  exempt from such  registration.  The
Company has not been advised of any definitive  selling  arrangement at the date
of this Prospectus  between the Selling  Stockholders  and any  broker-dealer or
agent.  It is also possible that the Selling  Stockholders  will attempt to sell
shares of Common Stock in block  transactions to purchasers at a price per share
which  may be below  the then  market  price.  Any  securities  covered  by this
Prospectus  which qualify for sale pursuant to Rule 144 under the Securities Act
may be sold under Rule 144 rather than pursuant to this  Prospectus.  The Shares
are being sold by the Selling  Stockholders  acting as principals  for their own
respective  accounts.  The Company will not be entitled to any proceeds from the
sale of any Shares sold by the Selling  Stockholders  as part of this  offering.
All expenses of registration incurred in connection with this offering are being
borne by the Company, but all brokerage  commissions and other expenses incurred
by the Selling Stockholders will be borne by the Selling Stockholders.

       In  connection  with  the   distribution  of  the  Shares,   the  Selling
Stockholders  may  enter  into  hedging  transactions  with  broker-dealers.  In
connection with such  transactions,  broker-dealers may engage in short sales of
the Shares in the course of hedging the  positions  they assume with the Selling
Stockholders.  The  Selling  Stockholders  may also  sell the  Shares  short and
redeliver the Shares to close out the short positions.  The Selling Stockholders
may also enter  into  option or other  transactions  with  broker-dealers  which
require  the  delivery  to  the   broker-dealer  of  the  Shares.   The  Selling
Stockholders  may also loan or pledge the Shares and such  lender or pledgee may
sell the  Shares so loaned or upon a default  may  effect  sales of the  pledged
shares.

       The Selling Stockholders and any dealer participating in the distribution
of Shares  or any  broker  executing  selling  orders  on behalf of the  Selling
Stockholders  may be deemed  to be  "underwriters"  within  the  meaning  of the
Securities  Act,  in which  event  any  profit  on the sale of any or all of the
Shares by them and any discounts or commissions  received by any such brokers or
dealers may be deemed to be  underwriting  discounts and  commissions  under the
Securities Act. Any broker or dealer participating in any distribution of Shares
in connection with the offering made hereby may be deemed to be an "underwriter"
within the meaning of the  Securities  Act and may be required to deliver a copy
of this  Prospectus,  including  a  Prospectus  Supplement,  to any  person  who
purchases any of the Shares from or through such broker or dealer.


                                       13

<PAGE>

                                  LEGAL MATTERS

       The legality of the securities offered hereby will be passed upon for the
Company by its General Counsel.

                                     EXPERTS

       The consolidated  financial  statements of American Banknote  Corporation
and  subsidiaries  as of  December  31,  1996 and 1995 and for each of the three
years in the period ended December 31, 1996  incorporated  in this Prospectus by
reference  from the  Company's  annual  Report on Form 10-K have been audited by
Deloitte & Touche LLP, independent  auditors, as stated in their report which is
incorporated  herein by reference and have been so incorporated in reliance upon
the report of such firm given upon their  authority as experts in accounting and
auditing.

       The  special  purpose  financial  statements  of  Leigh  Mardon  Security
Division  as of June 30,  1995 and 1994 and for each of the  three  years in the
period ended June 30, 1995 incorporated in this Prospectus by reference from the
Company's Current Repot on Form 8-K/A Amendment No. 1 dated August 14, 1996 have
been audited by KPMG, Chartered Accountants, as stated in their report, which is
incorporated  herein by refernece and have been so incorporated in reliance upon
the report of such firm given upon their  authiorty as experts in accounting and
auditing.


                                       14

<PAGE>

NO  PERSON  HAS  BEEN  AUTHORIZED  TO  GIVE  ANY  INFORMATION  OR  TO  MAKE  ANY
REPRESENTATIONS  OTHER THAN THOSE  CONTAINED IN THIS PROSPECTUS AND, IF GIVEN OR
MADE, SUCH INFORMATION OR REPRESENTATIONS MUST NOT BE RELIED UPON AS HAVING BEEN
AUTHORIZED BY THE COMPANY.  THIS PROSPECTUS DOES NOT CONSTITUTE AN OFFER TO SELL
OR THE  SOLICITATION  OF AN OFFER TO BUY ANY  SECURITY  OTHER THAN THE SHARES OF
COMMON  STOCK  OFFERED  HEREBY,  NOR  DOES IT  CONSTITUTE  AN OFFER TO SELL OR A
SOLICITATION  OF ANY  OFFER TO BUY  SHARES  OF  COMMON  STOCK BY  ANYONE  IN ANY
JURISDICTION IN WHICH SUCH OFFER OR SOLICITATION IS NOT AUTHORIZED,  OR IN WHICH
THE PERSON  MAKING SUCH OFFER OR  SOLICITATION  IS NOT QUALIFIED TO DO SO, OR TO
ANY PERSON TO WHOM IT IS  UNLAWFUL TO MAKE SUCH OFFER OR  SOLICITATION.  NEITHER
THE DELIVERY OF THIS  PROSPECTUS  NOR ANY SALE MADE HEREUNDER  SHALL,  UNDER ANY
CIRCUMSTANCES,  CREATE ANY  IMPLICATION  THAT  INFORMATION  CONTAINED  HEREIN IS
CORRECT AS OF ANY TIME SUBSEQUENT TO THE DATE HEREOF.


                                TABLE OF CONTENTS

                                                                            PAGE
                                                                            ----

Available Information.......................................................  3
Incorporation of Certain Documents
  by Reference..............................................................  3
The Company.................................................................  5
Recent Developments.........................................................  5
Use of Proceeds.............................................................  6
Risk Factors................................................................  6
Selling Stockholders ....................................................... 11
Plan of Distribution  ...................................................... 13
Legal Matters............................................................... 14
Experts..................................................................... 14


                                1,600,000 SHARES


                                AMERICAN BANKNOTE
                                   CORPORATION

                                  Common Stock

                                   ----------

                                   PROSPECTUS

                                   ----------

                                January __, 1998

<PAGE>

PART II

                     INFORMATION NOT REQUIRED IN PROSPECTUS


ITEM 14.  OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION.

       The table below sets forth the expenses expected to be incurred and borne
solely by the  Company  in  connection  with the  registration  of the shares of
Common Stock offered hereby:

            SEC registration fee........................       $2,419
            Legal fees and expenses.....................        5,000
            Accounting fees and expenses................        5,000
            Miscellaneous...............................        2,581

                Total...................................      $15,000


ITEM 15.  INDEMNIFICATION OF DIRECTORS AND OFFICERS.

         Section  145 of the  Delaware  General  Corporation  Law  (the  "DGCL")
provides for indemnification of directors and officers. If a director or officer
is  successful  on the merits or  otherwise  in a legal  proceeding,  he must be
indemnified against expenses, including attorney's fees, actually and reasonably
incurred by him in connection therewith.  Further,  indemnification is permitted
in both  third-party  and certain  derivative  suits if such director or officer
acted in good faith and for a purpose  he  reasonably  believed  was in the best
interests of the Company, and if, in the case of a criminal  proceeding,  he had
no reasonable cause to believe his conduct was unlawful.  Indemnification  under
this  provision  applies to judgments,  fines,  amounts paid in  settlement  and
reasonable  expenses,  in the case of third party  actions,  and amounts paid in
settlement  and reasonable  expenses,  in the case of derivative  actions.  In a
derivative action, however, a director or officer may not be indemnified for any
claim,  issue or matters as to which such person shall have been  adjudged to be
liable to the Company unless and to the extent that a court  determines that the
person is fairly and  reasonably  entitled to  indemnity.  Under  Delaware  law,
expenses may be advanced upon receipt of an  undertaking  by or on behalf of the
director  or  officer  to repay  the  amounts  in the  event  the  recipient  is
ultimately found not to be entitled to indemnification.

         The  Company's  Certificate  of  Incorporation  provides  that,  to the
fullest  extent  that the DGCL  permits the  limitation  or  elimination  of the
liability of directors, no director of the Company shall be personally liable to
the Company or its  stockholders  for  monetary  damages for breach of fiduciary
duties as a director.  In addition,  the Certificate of  Incorporation  provides
that the Company shall advance  expenses to the fullest extent  permitted by the
DGCL.  The Company  maintains  directors' and officers'  liability  insurance to
cover its directors and officers against certain liabilities they may incur when
acting in their capacity as directors or officers.

         Article VI of the  Company's  By-laws  provides  that any person made a
party to any action,  suit or proceeding by reason of the fact that he is or was
a director  or officer  of the  Company,  shall be  indemnified  by the  Company
against  the  expenses,  including  attorney's  fees,  actually  and  reasonably
incurred by him in connection with such action, or in connection with any appeal
therein,  if he acted in good faith and in a manner he reasonably believed to be
in or not opposed to the best interests of the


                                      II-1

<PAGE>

Company,  and, with respect to any criminal  action,  had no reasonable cause to
believe such conduct was unlawful.  Such right of  indemnification  shall not be
deemed  exclusive of any other  rights to which such  director or officer may be
entitled  under  any  statute,  By-Law,   agreement,  vote  of  shareholders  or
otherwise.

ITEM 16.  EXHIBITS.

         4.1      Indenture  dated as of May 15,  1992  between  the Company and
                  Chemical  Bank,  as Trustee,  relating  to the 10-3/8%  Senior
                  Notes due June 1, 2002 is incorporated  herein by reference to
                  Exhibit 4.2 to the Company's  Current Report on Form 8-K dated
                  May 26, 1992 (the "May 26, 1992 Form 8-K").

         4.2      Pledge Agreement, as amended, dated as of May 26, 1992 between
                  the Company and  Chemical  Bank,  as Trustee,  relating to the
                  Company's   10-3/8%   Senior   Notes   due  June  1, 2002 is 
                  incorporated  herein by reference  to Exhibit 4.3 to the 
                  May 26, 1992 Form 8-K.

         4.3      First Supplemental  Indenture to 10-3/8% Senior Notes due June
                  1, 2002 between the Company and Chemical Bank,  N.A., dated as
                  of May 23, 1994 is incorporated herein by reference to Exhibit
                  4.1 to the  Company's  Quarterly  Report  on Form 10-Q for the
                  quarter ended June 30, 1994 (the "June 30, 1994 10-Q.")

         4.4      First  Amendment to the Pledge  Agreement  dated as of May 26,
                  1992 between the Company and Chemical Bank,  N.A., dated as of
                  May 23, 1994 is  incorporated  herein by  reference to Exhibit
                  4.2 to the June 30, 1994 Form 10-Q.

         4.5      Indenture  dated as of May 1, 1994 between the Company and The
                  First  National  Bank of Boston,  as Trustee,  relating to the
                  11-5/8%  Senior  Notes Due  August 1,  2002,  Series B, of the
                  Company and Form of Series B Note, is  incorporated  herein by
                  reference to Exhibit 4.1 and 4.3 to the Company's Registration
                  Statement  on Form S-4 (File No.  33- 79726)  dated  August 5,
                  1994.

         4.6      Credit  Agreement  dated as of January 29, 1996 among American
                  Bank  Note  Company  and  American  Bank  Note   Holographics,
                  Inc.,the   Company  and  Chemical  Bank,  N.A.  as  Agent,  is
                  incorporated  herein by  reference  to Exhibit 4.8 to the 1995
                  10-K.

         4.7      Waiver and Amendment to Credit Agreement dated as of September
                  30, 1996 among  American  Bank Note Company and American  Bank
                  Note Holographics,  Inc., the Company, and The Chase Manhattan
                  Bank (formerly  Chemical Bank N.A.), as Agent, is incorporated
                  herein by reference to Exhibit 4.1 to the Company's  Quarterly
                  Report on Form 10-Q for the quarter  ended  September 30, 1996
                  (the "September 30, 1996 10-Q").

         4.8      Security  Agreement  dated  as  of  January  29,  1996,  among
                  American   Bank   Note   Company   and   American   Bank  Note
                  Holographics,  Inc.  and Chemical  Bank,  N.A.,  as Agent,  is
                  incorporated  herein by  reference  to Exhibit 4.9 to the 1995
                  10-K.


                                      II-2

<PAGE>

         4.9      Rights  Agreement  dated  as of March  24,  1994  between  the
                  Company and Chemical  Bank,  N.A., as Rights Agent,  including
                  the form of  Rights  Certificate  and form of  Certificate  of
                  Designation is  incorporated  herein by reference to Exhibit 1
                  to the  Company's  Current  Report on Form 8-K dated March 24,
                  1994.

         4.10     Waiver and Amendment to Credit Agreement dated as of March 25,
                  1997,  among American Bank Note Company and American Bank Note
                  Holographics,  Inc.,  American  Banknote  Corporation  and The
                  Chase  Manhattan  Bank, as Agent,  is  incorporated  herein by
                  reference to Exhibit 4.11 to the  Company's  Annual  Report on
                  Form 10-K for the year
                  ended December 31, 1996.

         4.11     Amendment to Credit Agreement dated as of April 14, 1997 among
                  American   Bank   Note   Company   and   American   Bank  Note
                  Holographics,  Inc., the Company and The Chase  Manhattan Bank
                  as Agent and Lender is  incorporated  herein by  reference  to
                  Exhibit 4.1 to the Company's Quarterly Report on Form 10-Q for
                  the quarter ended March 31, 1997.

         4.12     Zero Coupon Convertible  Subordinated Debenture dated July 24,
                  1997 in the  principal  amount of $5 million  is  incorporated
                  herein by reference to Exhibit 2.1 to the Company's  Quarterly
                  Report on Form 10-Q for the  quarter  ended June 30, 1997 (the
                  "June 30, 1997 10-Q").

         4.13     Amendment  to Credit  Agreement dated as of July 1, 1997 among
                  American   Bank  Note  Company  and  American   Bank  Note 
                  Holographics, Inc., the Company and the Chase Manhattan Bank,
                  as Agent and Lender, is incorporated herein by reference to 
                  Exhibit 4.1 to the June 30, 1997 10-Q.

         4.14     Amendment  to Credit Agreement  dated as of  November 14, 1997
                  among  American  Bank  Note  Company  and  American  Bank Note
                  Holographics, Inc., the Company and the Chase Manhattan Bank, 
                  as  Agent  and  Lender, is incorporated herein by reference to
                  Exhibit 4.1 to the  Company's Quarterly  Report  on  Form 10-Q
                  for  the  quarter ended September 30, 1997 (the "September 30,
                  1997 10-Q").

         4.15     Indenture for the 11 1/4% Senior  Subordinated Notes due 2007,
                  Series A (the "Old  Notes")  and 11 1/4%  Senior  Subordinated
                  Notes due 2007, Series B (the "Exchange  Notes"),  dated as of
                  December 12, 1997 among the Company,  the  Guarantors  and The
                  Bank of New  York,  as  trustee,  is  incorporated  herein  by
                  reference  to  Exhibit  4.1  to  the  Company's   Registration
                  Statement  on Form S-4 filed on January 9, 1998 (the  "January
                  9, 1998 Form S-4").

         4.16     Forms of Guarantee are incorporated herein by reference to 
                  Exhibit 4.2 to the January 9, 1998 Form S-4.             

         4.17     First  Supplement dated as of October 8, 1997 to the Indenture
                  dated as of May 1, 1994  between the Company and State  Street
                  Bank & Trust Company (as  successor to First  National Bank of
                  Boston), as Trustee,  relating to the 11 5/8% Senior Notes due
                  August 1, 2002, Series B, is incorporated herein by reference 
                  to Exhibit 4.5 to the January 9, 1998 Form S-4.              


                                      II-3

<PAGE>

         4.18     Registration  Rights  Agreement dated as of December 12, 1997
                  among  the Company,  the Guarantors and Chase Securities Inc.,
                  Bear, Sterns & Co. Inc., NationsBanc Montgomery Securities, 
                  Inc.  and   Societe  Generale  Securities  Corporation   is 
                  incorporated herein by reference to Exhibit 4.6 to the January
                  9, 1998 Form S-4.

         10.1     Securities  Purchase  Agreement by and among American Banknote
                  Corporation,  RGC  International  Investors,  LDC and  Halifax
                  Fund,  L.P.,  dated as of November  25,  1997 is  incorporated
                  herein by reference to Exhibit 10.1 to the  Company's  Current
                  Report on Form 8-K dated  November 25, 1997 (the "November 25,
                  1997 Form 8-K").

         10.2     Form of Zero Coupon Convertible Subordinated Debenture,  dated
                  November  25,  1997 is  incorporated  herein by  reference  to
                  Exhibit 10.2 to the November 25, 1997 Form 8-K.

         10.3     Form of Warrant to purchase  150,000 shares of common stock of
                  American  Banknote  Corporation,  dated  November  25, 1997 is
                  incorporated  herein  by  reference  to  Exhibit  10.3  to the
                  November
                  25, 1997 Form 8-K.

         10.4     Registration  Rights Agreement by and among American  Banknote
                  Corporation,  RGC  International  Investors,  LDC and  Halifax
                  Fund,  L.P.,  dated as of November  25,  1997 is  incorporated
                  herein by  reference  to Exhibit 10.4 to the November 25, 1997
                  Form 8-K.

         5        Opinion of the Company's General Counsel.*

         23.1     Consent of Deloitte & Touche LLP.*

         23.2     Consent of KPMG.*

         23.3     Consent of the Company's General Counsel.
                  (Included in Exhibit 5).*

*Filed herewith


                                      II-4

<PAGE>

ITEM 17.  UNDERTAKINGS

The undersigned registrant hereby undertakes:

         (1) To file, during any period in which offers or sales are being made,
a  post-effective  amendment  to this  registration  statement  to  include  any
material  information  with respect to the plan of  distribution  not previously
disclosed  in  the  registration  statement  or  any  material  change  to  such
information in the registration statement;

         (2) That,  for the  purpose  of  determining  any  liability  under the
Securities Act, each such  post-effective  amendment shall be deemed to be a new
registration  statement  relating to the  securities  offered  therein,  and the
offering of such  securities at that time shall be deemed to be the initial bona
fide offering thereof.

         (3) To remove from registration by means of a post-effective  amendment
any of the securities being registered which remain unsold at the termination of
the offering.

         The  undersigned  registrant  hereby  undertakes  that, for purposes of
determining  any  liability  under  the  Securities  Act,  each  filing  of  the
registrant's  annual  report  pursuant to Section  13(a) or Section 15(d) of the
Exchange Act that is  incorporated  by reference in the  registration  statement
shall be deemed to be a new  registration  statement  relating to the securities
offered  therein,  and the  offering  of such  securities  at that time shall be
deemed to be the initial bona fide offering thereof.

         Insofar as indemnification for liabilities arising under the Securities
Act of 1933 may be permitted to directors,  officers and controlling  persons of
the  registrant  pursuant  to  the  foregoing  provisions,   or  otherwise,  the
registrant  has been advised that in the opinion of the  Securities and Exchange
Commission such indemnification is against public policy as expressed in the Act
and is, therefore,  unenforceable. In the event that a claim for indemnification
against such  liabilities  (other than the payment by the registrant of expenses
incurred or paid by a director,  officer or controlling person of the registrant
in the successful defense of any action, suit or proceeding) is asserted by such
director,  officer or controlling person in connection with the securities being
registered, the registrant will, unless in the opinion of its counsel the matter
has been  settled by  controlling  precedent,  submit to a court of  appropriate
jurisdiction the question whether such  indemnification  by it is against public
policy as expressed in the Act and will be governed by the final adjudication of
such issue.


                                      II-5

<PAGE>

                                   SIGNATURES

         Pursuant  to the  requirements  of the  Securities  Act  of  1933,  the
registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form S-3 and has duly caused this registration
statement  to be  signed  on its  behalf  by  the  undersigned,  thereunto  duly
authorized,  in the  City of New  York,  State  of New  York on this  8th day of
January, 1998

                                       AMERICAN BANKNOTE CORPORATION

                                       By:  /s/ John T. Gorman
                                            ---------------------------
                                            John T. Gorman
                                            Executive Vice President
                                            and Chief Financial Officer


         Each person, in so signing, also makes, constitutes and appoints MORRIS
WEISSMAN,  Chairman of the Board of Directors  and Chief  Executive  Officer and
JOHN T. GORMAN,  Executive Vice  President,  Chief  Financial  Officer and Chief
Accounting Officer of American Banknote Corporation,  and each of them, his true
and lawful attorney-in-fact,  in his name, place and stead, to execute and cause
to be filed  with the  Commission  any or all  amendments  to this  registration
statement.

         PURSUANT TO THE  REQUIREMENTS OF THE SECURITIES ACT, THIS  REGISTRATION
STATEMENT  HAS BEEN  SIGNED  BELOW BY OR ON BEHALF OF THE  FOLLOWING  PERSONS ON
JANUARY 8, 1998 IN THE CAPACITIES INDICATED BELOW.

         Signature                                Title
         ---------                                -----

/s/ Morris Weissman                         
- ----------------------------------          Chairman of the Board of Directors 
Morris Weissman                             and Chief Executive Officer 
                                            (principal executive officer)

/s/ John T. Gorman
- ----------------------------------          Executive Vice President and Chief 
John T. Gorman                              Financial Officer (principal 
                                            financial and accounting officer)


/s/ Bette B. Anderson
- ----------------------------------          Director
Bette B. Anderson


/s/ Dr. Oscar S. Arias
- ----------------------------------          Director
Dr. Oscar S. Arias


/s/ C. Gerald Goldsmith
- ----------------------------------          Director
C. Gerald Goldsmith


/s/ Ira J. Hechler
- ----------------------------------          Director
Ira J. Hechler


/s/ David S. Rowe-Beddoe
- ----------------------------------          Director
David S. Rowe-Beddoe


/s/ Alfred Teo
- ----------------------------------          Director
Alfred Teo







                                                                       Exhibit 5

                         [American Banknote Letterhead]

                                                             January 8, 1998

Securities and Exchange Commission
450 Fifth Street, N.W.
Judiciary Plaza
Washington, D.C. 20549

            Re:  Registration Statement on Form S-3
                 ----------------------------------

Ladies and Gentlemen:

         I have acted as counsel to American  Banknote  Corporation,  a Delaware
corporation (the "Company"),  in connection with the preparation and filing of a
Registration  Statement  on Form S-3 (the  "Registration  Statement")  under the
Securities Act of 1933, as amended (the "Securities Act"), relating to 1,600,000
shares (the "Shares") of common stock,  par value $.01 per share, of the Company
(the "Common Stock").

         As such counsel, I have examined such corporate  records,  certificates
and other  documents  as I have  considered  necessary  or  appropriate  for the
purposes of this  opinion.  In rendering  this  opinion,  I have assumed (i) the
genuineness  of  all   signatures  on  documents  I  have  examined,   (ii)  the
authenticity of all documents, and (iii) the conformity to original documents of
all documents  submitted as photostatic or conformed copies and the authenticity
of the originals of such copies.  I have also relied on  certificates  of public
officials and, as to matters of fact, statements and certificates of officers of
the Company.

         Based upon the foregoing, I am of the opinion that:

         (1) The  Shares  have  been  validly  authorized  and  issued,  and are
fully-paid and non-assessable shares of Common Stock.

         I am a member  of the bar of the  State of New  York and I  express  no
opinion  as to the laws of any  other  jurisdiction  other  than the laws of the
United  States  of  America  and the  General  Corporation  Law of the  State of
Delaware.

         I  consent  to  the  filing  of  this  opinion  as an  exhibit  to  the
Registration Statement. In giving such consent I do not hereby concede that I am
within the category of persons whose consent is required  under Section 7 of the
Securities Act or the rules and regulations promulgated thereunder.

         I am  delivering  this  opinion  solely for your  benefit  and no other
person is entitled to rely upon it without  prior  written  consent.  Very truly
yours,

                              /s/ Harvey J. Kesner
                              --------------------
                                 Harvey J. Kesner





                                                                    EXHIBIT 23.1




INDEPENDENT AUDITORS' CONSENT


We consent to the incorporation by reference in this  Registration  Statement of
American Banknote Corporation on Form S-3 of our report dated February 21, 1997,
appearing in the Annual Report on Form 10-K of American Banknote Corporation for
the year  ended  December  31,  1996,  as  amended  on Form  10-K/A,  and to the
reference to us under the heading  "Experts" which is part of this  Registration
Statement.


DELOITTE & TOUCHE LLP
New York, New York
January 9, 1998






                                                                    EXHIBIT 23.2





INDEPENDENT AUDITORS' CONSENT

We consent to the incorporation by reference,  in this Registration Statement of
American Banknote Corporation on Form S-3, of our report dated 14 August 1996 on
the special purpose financial  statements of Leigh Mardon Security Division (the
"Economic  Entity")  as  defined in Note 1 thereto,  as  included  in Form 8-K/A
Amendment No. 1 dated August 14, 1996, of American Banknote  Corporation for the
year ended  December  31,  1996,  and to the  reference  to us under the heading
"Experts" which is part of this Registration Statement.



KPMG
Melbourne, Australia
January 8, 1998




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission